NASDAQ:PRTA
Prothena Corporation plc Stock News
$22.52
-0.87 (-3.72%)
At Close: May 17, 2024
Prothena to Participate in JMP Securities Hematology and Oncology Summit
09:05pm, Monday, 29'th Nov 2021 GlobeNewswire Inc.
DUBLIN, Ireland, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built
Prothena to Participate in JMP Securities Hematology and Oncology Summit
09:05pm, Monday, 29'th Nov 2021 Intrado Digital Media
DUBLIN, Ireland, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that members of its senior management team will participate in a fireside chat at the JMP Securities Hematology and Oncology Summit on Monday December 6, 2021 at 1:20 PM ET.
-$0.71 Earnings Per Share Expected for Prothena Co. plc (NASDAQ:PRTA) This Quarter
09:06pm, Saturday, 27'th Nov 2021 Dakota Financial News
Wall Street brokerages forecast that Prothena Co. plc (NASDAQ:PRTA) will report earnings per share of ($0.71) for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for Prothenas earnings. The lowest EPS estimate is ($0.84) and the highest is ($0.52). Prothena reported earnings of ($0.77) per share in the same quarter last []
Karin L. Walker Sells 4,519 Shares of Prothena Co. plc (NASDAQ:PRTA) Stock
01:06pm, Saturday, 27'th Nov 2021 Dakota Financial News
Prothena Co. plc (NASDAQ:PRTA) CAO Karin L. Walker sold 4,519 shares of the companys stock in a transaction that occurred on Tuesday, November 23rd. The shares were sold at an average price of $57.88, for a total value of $261,559.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is []
AQR Capital Management LLC Takes Position in Prothena Co. plc (NASDAQ:PRTA)
11:34am, Tuesday, 23'rd Nov 2021 Transcript Daily
AQR Capital Management LLC purchased a new stake in shares of Prothena Co. plc (NASDAQ:PRTA) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 4,917 shares of the biotechnology companys stock, valued at approximately $253,000. A number of other large investors have also modified []
Prothena (NASDAQ:PRTA) Now Covered by Analysts at JMP Securities
06:56am, Tuesday, 23'rd Nov 2021 Transcript Daily
JMP Securities started coverage on shares of Prothena (NASDAQ:PRTA) in a report issued on Friday morning, PriceTargets.com reports. The firm issued an outperform rating and a $77.00 target price on the biotechnology companys stock. PRTA has been the topic of several other research reports. Royal Bank of Canada upped their target price on shares of []
Prothena (NASDAQ:PRTA) Shares Gap Up to $54.59
08:28am, Sunday, 21'st Nov 2021 Transcript Daily
Prothena Co. plc (NASDAQ:PRTA) gapped up before the market opened on Friday . The stock had previously closed at $54.59, but opened at $56.69. Prothena shares last traded at $59.19, with a volume of 1,082 shares. A number of brokerages have issued reports on PRTA. Zacks Investment Research downgraded Prothena from a buy rating to []
Boom Or Bust: Where Is Prothena Corporation plc (NASDAQ: PRTA) Stock Headed Next?
05:00pm, Saturday, 20'th Nov 2021 Marketing Sentinel
Prothena Corporation plc (NASDAQ:PRTA)s traded shares stood at 0.35 million during the last session, with the companys beta value hitting 1.21. At the close of trading, the stocks price was $58.73, to imply an increase of 7.58% or $4.14 in intraday trading. The PRTA shares 52-week high remains $79.75, putting it -35.79% down since that Boom Or Bust: Where Is Prothena Corporation plc (NASDAQ: PRTA) Stock Headed Next? Read More »
Insider Selling: Prothena Co. plc (NASDAQ:PRTA) Insider Sells 10,000 Shares of Stock
04:04am, Saturday, 20'th Nov 2021 Transcript Daily
Prothena Co. plc (NASDAQ:PRTA) insider Michael J. Malecek sold 10,000 shares of the businesss stock in a transaction on Friday, November 19th. The stock was sold at an average price of $55.00, for a total transaction of $550,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through []
Analyst Ratings For Prothena Corp
05:00pm, Friday, 19'th Nov 2021 Business Insider Markets
Within the last quarter, Prothena Corp (NASDAQ: PRTA ) has observed the following analyst ratings:
Cassava (SAVA) Down on Report of SEC Investigation Into AD Program
01:43pm, Thursday, 18'th Nov 2021 Zacks Investment Research
Cassava (SAVA) tanks on reports of an investigation by the SEC related to data reports on its AD candidate.
Charles Schwab Investment Management Inc. Has $10.63 Million Stock Holdings in Prothena Co. plc (NASDAQ:PRTA)
11:02am, Wednesday, 17'th Nov 2021 Dakota Financial News
Charles Schwab Investment Management Inc. lifted its holdings in shares of Prothena Co. plc (NASDAQ:PRTA) by 11.0% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 206,826 shares of the biotechnology company’s stock after buying an additional 20,435 shares during the period. Charles Schwab Investment Management […]
Syntal Capital Partners, LLC Buys Blackstone Inc, Boot Barn Holdings Inc, Prothena Corp PLC, ...
12:38am, Tuesday, 16'th Nov 2021 GuruFocus
Related Stocks: INTU , CROX , BX , BOOT , PRTA , HCA , DDS , SPLG , XLE , STLD , DELL , ALLY , TGT , EL ,
An Alzheimer's Bubble That Was Well & Truly Burst May Be Blowing Up Again - Here's Why
11:15am, Wednesday, 10'th Nov 2021
An Alzheimer's Bubble That Was Well & Truly Burst May Be Blowing Up Again - Here's Why
Prothena (PRTA) Q3 Earnings Miss, Pipeline Progress in Focus
10:42am, Friday, 05'th Nov 2021
Prothena misses on earnings and revenues in the third quarter of 2021. Nevertheless, the company's progress with its AD pipeline is encouraging.